Betulinic acid sensitizes temozolomide-resistant glioblastoma cells through downregulation of Sp1

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - Jul 2018
EventThe 18th World Congress of Basic and Clinical Pharmacology - Kyoto, Japan
Duration: Jul 1 2018Jul 6 2018

Conference

ConferenceThe 18th World Congress of Basic and Clinical Pharmacology
Country/TerritoryJapan
CityKyoto
Period7/1/187/6/18

Cite this